Alan Clucas

844 total citations
13 papers, 476 citations indexed

About

Alan Clucas is a scholar working on Dermatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Alan Clucas has authored 13 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Dermatology, 5 papers in Epidemiology and 2 papers in Infectious Diseases. Recurrent topics in Alan Clucas's work include Acne and Rosacea Treatments and Effects (6 papers), Dermatology and Skin Diseases (5 papers) and Nail Diseases and Treatments (4 papers). Alan Clucas is often cited by papers focused on Acne and Rosacea Treatments and Effects (6 papers), Dermatology and Skin Diseases (5 papers) and Nail Diseases and Treatments (4 papers). Alan Clucas collaborates with scholars based in France, United States and Australia. Alan Clucas's co-authors include Michèle Verschoore, Michel Poncet, Andrew Alexis, Christophe Piketty, Grażyna Pulka, Dédée F. Murrell, Yves Poulin, Jean‐David Bouaziz, Andreas Wollenberg and Faiz Ahmad and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Journal of the American Academy of Dermatology and Drugs.

In The Last Decade

Alan Clucas

13 papers receiving 451 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alan Clucas France	10	373	138	73	69	61	13	476
M Mattii Italy	10	356 1.0×	67 0.5×	93 1.3×	30 0.4×	278 4.6×	13	528
William D. Boothe United States	4	306 0.8×	185 1.3×	65 0.9×	52 0.8×	61 1.0×	7	373
James Tarbox United States	8	299 0.8×	190 1.4×	82 1.1×	90 1.3×	108 1.8×	20	465
Yoshiko Sakaguchi Japan	10	231 0.6×	110 0.8×	160 2.2×	42 0.6×	312 5.1×	16	537
Anna Chiara Fostini Italy	7	188 0.5×	45 0.3×	46 0.6×	67 1.0×	204 3.3×	7	356
Henz Germany	6	86 0.2×	96 0.7×	70 1.0×	67 1.0×	166 2.7×	6	312
Akiko Takaoka Japan	9	250 0.7×	140 1.0×	170 2.3×	88 1.3×	189 3.1×	18	486
Timothy P. Kingston United Kingdom	10	123 0.3×	20 0.1×	29 0.4×	36 0.5×	76 1.2×	21	282
Drew H. Barnes United States	4	337 0.9×	23 0.2×	132 1.8×	62 0.9×	514 8.4×	4	646
Douglass W. Forsha United States	4	485 1.3×	394 2.9×	151 2.1×	87 1.3×	43 0.7×	15	562

Countries citing papers authored by Alan Clucas

Since Specialization

Citations

This map shows the geographic impact of Alan Clucas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Clucas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Clucas more than expected).

Fields of papers citing papers by Alan Clucas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Clucas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Clucas. The network helps show where Alan Clucas may publish in the future.

Co-authorship network of co-authors of Alan Clucas

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Clucas. A scholar is included among the top collaborators of Alan Clucas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Clucas. Alan Clucas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Silverberg, Jonathan I., Andreas Pinter, Grażyna Pulka, et al.. (2019). Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus. Journal of Allergy and Clinical Immunology. 145(1). 173–182. 184 indexed citations

Harness, Jane, et al.. (2010). Can sebum reduction predict acne outcome?. British Journal of Dermatology. 163(4). 683–688. 44 indexed citations

Borregaard, Jeanett, Lone Skov, Lisy Wang, et al.. (2008). Evaluation of the effect of the specific CCR1 antagonist CP‐481715 on the clinical and cellular responses observed following epicutaneous nickel challenge in human subjects. Contact Dermatitis. 59(4). 212–219. 10 indexed citations

Clucas, Alan, Ajit Shah, Yuanchao Zhang, Vincent Chow, & Ronald P. Gladue. (2007). Phase I Evaluation of the Safety,??Pharmacokinetics and Pharmacodynamics of CP-481,715. Clinical Pharmacokinetics. 46(9). 757–766. 25 indexed citations

Gladue, Ronald P., Samuel H. Zwillich, Alan Clucas, & Matthew F. Brown. (2004). CCR1 antagonists for the treatment of autoimmune diseases.. PubMed. 5(5). 499–504. 22 indexed citations

Queille‐Roussel, Catherine, et al.. (2001). Comparison of the cumulative irritation potential of adapalene gel and cream with that of erythromycin/tretinoin solution and gel and erythromycin/isotretinoin gel. Clinical Therapeutics. 23(2). 205–212. 30 indexed citations

Erp, P.E.J. van, et al.. (2000). CD 2394, a novel synthetic retinoid, initiates an embryonic type of differentiation in hyperproliferative skin. Acta Dermato Venereologica. 80(2). 98–101. 1 indexed citations

Clucas, Alan, et al.. (1997). Adapalene 0.1% gel is better tolerated than tretinoin 0.025% gel in acne patients. Journal of the American Academy of Dermatology. 36(6). S116–S118. 35 indexed citations

Verschoore, Michèle, et al.. (1997). Adapalene 0.1% gel has low skin-irritation potential. Journal of the American Academy of Dermatology. 36(6). S104–S109. 44 indexed citations

10.

Kerrouche, Nabil, et al.. (1997). Split-face comparison of adapalene 0.1% gel and tretinoin 0.025% gel in acne patients. Journal of the American Academy of Dermatology. 36(6). S110–S112. 36 indexed citations

11.

Clucas, Alan, et al.. (1997). Skin tolerance of adapalene 0.1% gel in combination with other topical antiacne treatments. Journal of the American Academy of Dermatology. 36(6). S113–S115. 28 indexed citations

12.

Pinquier, J.L., René Bruno, François Bompart, et al.. (1991). Inhibition of ex-vivo PAF-induced platelet aggregation by the PAF-antagonist RP 48740: relationship to plasma concentrations in healthy volunteers. European Journal of Clinical Pharmacology. 41(2). 141–5. 8 indexed citations

13.

Clucas, Alan & N. Miller. (1988). Effects of Acebutolol on the Serum Lipid Profile. Drugs. 36(Supplement 2). 41–50. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact